In The Gambia, the increase seen in prostate cancer may be due to an artefact, specifically, improvement in case ascertainment in the PBCR as a result of the recent availability and increased utilisation of serum prostate-specific antigen (PSA) testing in the country. The gene discussed is KLK3; the disease is prostate cancer.